The ‘gateway’ drug theory: Cannabis vs alcohol examined

18/08/2023
Cannabis vs. Alcohol

Debunking the 'Gateway' Myth: Cannabis vs. alcohol

For years, cannabis has been labelled as a 'gateway' drug, leading to the use of stronger and potentially more dangerous substances. However, a groundbreaking study has shed new light on this topic, suggesting that young individuals are more likely to try alcohol before cannabis or tobacco.

The study's findings

A recent study, believed to be the first of its kind, delved into the patterns of substance use among young people. The research aimed to determine which substances were tried first and whether the order of substance initiation had any implications for future use.

The study analysed data from over 8,000 young individuals, focusing on their experiences with alcohol, cannabis, and tobacco.

The findings were revealing:

  • Young people predominantly tried alcohol before any other substance.
  • Only a mere 6% of participants tried cannabis before alcohol or tobacco.
  • 21.8% of those who had used cannabis reported trying it at the same age as alcohol or tobacco.

Implications for substance misuse

Interestingly, the study found that individuals who tried cannabis before alcohol or tobacco were less likely to have substance misuse issues in the future.

This challenges the long-standing belief that cannabis acts as a stepping stone to harder drugs. In fact, the study's authors concluded that deterring simultaneous initiation of multiple substances could have significant public health benefits.

Other research supports the findings

This isn't the only study to challenge the 'gateway' theory. Research from the University of Washington in 2022 found that the legalisation of cannabis for adult use led to decreased consumption of alcohol, nicotine, and non-prescribed pain medication among young adults.

This further refutes the idea that cannabis legalisation would lead to increased substance misuse in society.

Conclusion: Time to rethink the 'Gateway' Theory?

With mounting evidence against the 'gateway' theory, it's time for a more nuanced understanding of cannabis and its role in society. As more states and countries move towards cannabis legalisation, it's crucial to base policies on evidence and research rather than outdated beliefs.

As the debate continues, one thing is clear: cannabis's role as a 'gateway' drug is far from settled, and more research is needed to fully understand its implications for public health.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.

Robin Roy Krigslund-Hansen

Robin Roy Krigslund-Hansen

About the author:

Robin Roy Krigslund-Hansen is known for his extensive knowledge and expertise in the fields of CBD and hemp production. With a career spanning over a decade in the cannabis industry, he has dedicated his life to understanding the intricacies of these plants and their potential benefits to human health and the environment. Over the years, Robin has worked tirelessly to promote the full legalisation of hemp in Europe. His fascination with the plant's versatility and potential for sustainable production led him to pursue a career in the field.

More about Robin Roy Krigslund-Hansen

Related products

1 of 3